BRCA1 and ovarian carcinoma: BRCA2/ex1-14del, identified in Colombian breast/ovarian cancer families, represents the second founder LGR identified in a Hispanic population after BRCA1/ex9-12del, which is a common Mexican founder mutation17, 18.